Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 38.0539.68---

What is the latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of MANKIND PHARMA is 38.05 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202538.05
Mar202439.68
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of MANKIND PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 38.05
-4.11
Mar2024 39.68
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of MANKIND PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,302.2 Cr 1.5% -3.5% -10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,872.0 Cr 0.6% 3.6% -12.5% Stock Analytics
DIVIS LABORATORIES ₹175,706.0 Cr 1% 9.4% 8% Stock Analytics
CIPLA ₹127,449.0 Cr 0.9% 1.2% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,125.0 Cr 1.7% 1% 1% Stock Analytics
DR REDDYS LABORATORIES ₹104,827.0 Cr -0.5% -4.2% -6.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-3.5%

-10.6%

SENSEX

1.8%

1.9%

2.4%


You may also like the below Video Courses